| Date Filed | Type | Description |
| 07/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/18/2023 |
4
| Novo Holdings A/S (10% Owner) has filed a Form 4 on Cyteir Therapeutics, Inc.|
Txns:
| Sold 11,000 shares
@ $2.7365, valued at
$30.1k
Sold 21,100 shares
@ $2.7488, valued at
$58k
Sold 6,500 shares
@ $2.7574, valued at
$17.9k
|
|
| 07/03/2023 |
4
| Novo Holdings A/S (10% Owner) has filed a Form 4 on Cyteir Therapeutics, Inc.|
Txns:
| Sold 200,937 shares
@ $2.6341, valued at
$529.3k
|
|
| 06/28/2023 |
4
| Novo Holdings A/S (10% Owner) has filed a Form 4 on Cyteir Therapeutics, Inc.|
Txns:
| Sold 8,437 shares
@ $1.7905, valued at
$15.1k
Sold 31,978 shares
@ $1.7727, valued at
$56.7k
|
|
| 02/07/2023 |
4
| Zakrzewski Joseph S (Director) has filed a Form 4 on Cyteir Therapeutics, Inc.|
Txns:
| Granted 14,150 options to buy
@ $1.69, valued at
$23.9k
|
|
| 02/07/2023 |
4
| THERO JOHN F (Director) has filed a Form 4 on Cyteir Therapeutics, Inc.|
Txns:
| Granted 12,828 options to buy
@ $1.69, valued at
$21.7k
|
|
| 02/07/2023 |
4
| Sands Stephen H. (Director) has filed a Form 4 on Cyteir Therapeutics, Inc.|
Txns:
| Granted 12,129 options to buy
@ $1.69, valued at
$20.5k
|
|
| 02/07/2023 |
4
| Romberger Timothy (Director) has filed a Form 4 on Cyteir Therapeutics, Inc.|
Txns:
| Granted 14,150 options to buy
@ $1.69, valued at
$23.9k
|
|
| 02/07/2023 |
4
| Molineaux Susan (Director) has filed a Form 4 on Cyteir Therapeutics, Inc.|
Txns:
| Granted 14,150 options to buy
@ $1.69, valued at
$23.9k
|
|
| 02/07/2023 |
4
| Humphrey Jeffrey (Director) has filed a Form 4 on Cyteir Therapeutics, Inc.|
Txns:
| Granted 14,150 options to buy
@ $1.69, valued at
$23.9k
|
|
| 02/07/2023 |
4
| George Jean (Director) has filed a Form 4 on Cyteir Therapeutics, Inc.|
Txns:
| Granted 14,150 options to buy
@ $1.69, valued at
$23.9k
|
|
| 02/07/2023 |
4
| Bracken Racquel (Director) has filed a Form 4 on Cyteir Therapeutics, Inc.|
Txns:
| Granted 14,150 options to buy
@ $1.69, valued at
$23.9k
|
|
| 02/07/2023 |
4
| Gaiero David G (CFO) has filed a Form 4 on Cyteir Therapeutics, Inc.|
Txns:
| Granted 5,000 shares
@ $1.49, valued at
$7.5k
Granted 113,900 options to buy
@ $1.69, valued at
$192.5k
|
|
| 02/07/2023 |
4
| Gaiero David G (CFO) has filed a Form 4 on Cyteir Therapeutics, Inc.|
Txns:
| Exercised 4,100 shares
@ $1.68, valued at
$6.9k
Exercised 4,100 options to buy
@ $0 |
|
| 02/07/2023 |
4
| Veness Adam M (General Counsel) has filed a Form 4 on Cyteir Therapeutics, Inc.|
Txns:
| Granted 96,100 options to buy
@ $1.69, valued at
$162.4k
|
|
| 02/07/2023 |
4
| RENSCHLER MARKUS MD (President and CEO) has filed a Form 4 on Cyteir Therapeutics, Inc.|
Txns:
| Granted 5,000 shares
@ $1.49, valued at
$7.5k
Granted 302,600 options to buy
@ $1.69, valued at
$511.4k
|
|
| 12/23/2022 |
4
| RENSCHLER MARKUS MD (President and CEO) has filed a Form 4 on Cyteir Therapeutics, Inc.|
Txns:
| Exercised 106,345 shares
@ $1.03, valued at
$109.5k
Exercised 30,437 shares
@ $1.2, valued at
$36.5k
Exercised 106,345 options to buy
@ $0
Exercised 30,437 options to buy
@ $0 |
|
| 12/08/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 12/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/22/2022 |
4
| Novo Holdings A/S (10% Owner) has filed a Form 4 on Cyteir Therapeutics, Inc.|
Txns:
| Sold 900,000 shares
@ $3, valued at
$2.7M
|
|
| 05/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/12/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/12/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/04/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/24/2022 |
4
| RENSCHLER MARKUS MD (President and CEO) has filed a Form 4 on Cyteir Therapeutics, Inc.|
Txns:
| Granted 106,200 options to buy
@ $5.96, valued at
$633k
|
|
| 02/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/24/2022 |
4
| Humphrey Jeffrey (Director) has filed a Form 4 on Cyteir Therapeutics, Inc.|
Txns:
| Granted 2,358 options to buy
@ $5.96, valued at
$14.1k
|
|
| 02/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/24/2022 |
4
| Bracken Racquel (Director) has filed a Form 4 on Cyteir Therapeutics, Inc.|
Txns:
| Granted 14,150 options to buy
@ $5.96, valued at
$84.3k
|
|
| 02/24/2022 |
4
| Romberger Timothy (Director) has filed a Form 4 on Cyteir Therapeutics, Inc.|
Txns:
| Granted 14,150 options to buy
@ $5.96, valued at
$84.3k
|
|
| 02/24/2022 |
4
| Naesens Janwillem (Director) has filed a Form 4 on Cyteir Therapeutics, Inc.|
Txns:
| Granted 14,150 options to buy
@ $5.96, valued at
$84.3k
|
|
| 02/24/2022 |
4
| Secrist John Paul (Chief Scientific Officer) has filed a Form 4 on Cyteir Therapeutics, Inc.|
Txns:
| Granted 42,000 options to buy
@ $5.96, valued at
$250.3k
|
|
|